Methods of making deuterated cyclosporin analogs
View Patent ↗Cyclosporine derivatives are disclosed which possess enhanced efficacy and reduced toxicity over naturally occurring and other presently known cyclosporins and cyclosporine derivatives. The cyclosporine derivatives of the present invention are produced by chemical and isotopic substitution of the cyclosporine A (CsA) molecule by: (1) Chemical substitution and optionally deuterium substitution of amino acid 1; and (2) deuterium substitution at key sites of metabolism of the cyclosporine A molecule such as amino acids 1, 4, 9. Also disclosed are methods of producing the cyclosporine derivatives and method of producing immunosuppression with reduced toxicity with the disclosed cyclosporine derivatives.
1. A method for making a cyclosporin A derivative having the structure:
wherein R is an unsaturated straight or branched aliphatic carbon chain of from 2 to 3 carbons, the method comprising:
(a) protecting the β-alcohol of cyclosporin A, thereby forming an intermediate acetyl cyclosporin A;
(b) oxidizing the acetyl cyclosporin A to produce an intermediate acetyl cyclosporin A aldehyde;
(c) treating the intermediate acetyl cyclosporin A aldehyde in a Wittig reaction with a phosphorus ylide formed by treating an alkyl or aryl triphenyl phosphonium halide with a base to produce an acetyl cyclosporin A derivative; and
(d) hydrolyzing the acetyl cyclosporin A derivative with a base.
2. The method of claim 1 , wherein the oxidizing is carried out with an oxidizing agent selected from the group consisting of ozone, potassium permanganate, and osmium tetroxide.
3. The method of claim 2 , wherein the oxidizing agent is osmium tetroxide.
4. A method for making a cyclosporine A derivative having the structure:
wherein R is a saturated or unsaturated, straight or branched, aliphatic carbon chain of from 2 to 3 carbons that is substituted with one or more deuterium atoms, the method comprising:
(a) protecting the β-alcohol of cyclosporin A, thereby forming an intermediate acetyl cyclosporin A;
(b) oxidizing the acetyl cyclosporin A to produce an intermediate acetyl cyclosporin A aldehyde;
(c) treating the intermediate acetyl cyclosporin A aldehyde in a Wittig reaction with a phosphorus ylide formed by treating an alkyl or aryl triphenyl phosphonium halide with a base to produce an acetyl cyclosporine A derivative; and
(d) hydrolyzing the acetyl cyclosporin A derivative with a base.
5. The method of claim 4 , wherein the oxidizing is carried out with an oxidizing agent selected from the group consisting of ozone, potassium permanganate, and osmium tetroxide.
6. The method of claim 5 , wherein the oxidizing agent is osmium tetroxide.
7. A method for making a cyclosporin A derivative having the structure:
wherein R is a member selected from the group consisting of —D, —CH═CD—CD 3 , —CD═CD—CD 3 , —CH═CH—CH═CD—CD 3 , —CD═CH—CD═CD—CD 3 , —CH═CH—CH═CD 2 , —CD═CH—CD═CD 2 , —CH═CD 2 , —CD═CD 2 , —CH═CH 2 , —CH═CH—CD 3 , —CH═CH—CH 3 , —CH═CH—CH═CH—CH 3 , and —CH═CH—CH═CH 2 ,
the method comprising:
(a) protecting the β-alcohol of cyclosporin A, thereby forming an intermediate acetyl cyclosporin A;
(b) oxidizing the acetyl cyclosporin A to produce an intermediate acetyl cyclosporin A aldehyde;
(c) treating the intermediate acetyl cyclosporin A aldehyde in a Wittig reaction with a phosphorus ylide formed by treating an alkyl or aryl triphenyl phosphonium halide with a base to produce an acetyl cyclosporine A derivative; and
(d) hydrolyzing the acetyl cyclosporin A derivative with a base.
8. The method of claim 7 , wherein the oxidizing is carried out with an oxidizing agent selected from the group consisting of ozone, potassium permanganate, and osmium tetroxide.
9. The method of claim 8 , wherein the oxidizing agent is osmium tetroxide.
10. The method of claim 1 , wherein the phosphorus ylide has formula RCH=PPh 3.
11. The method of claim 4 , wherein the phosphorus ylide has formula RCH=PPh 3.
12. The method of 7 , wherein the phosphorus ylide has formula RCH=PPh 3.